MSNBA

Overview

MSNBA is a potent and selective GLUT5 fructose transport inhibitor with an IC 50 of 0.10 mM. MSNBA does not affect the transport activity of human GLUT1 , GLUT2 , GLUT3 , GLUT4 or bacterial GlcPSe. MSNBA competitively inhibits GLUT5 fructose uptake with a K i of 3.2 μM in MCF7 cells. MSNBA can be used for the study of cancer or diabetes.

Application

Products | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Bacterial Infection | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > GLUT

Product Information

• Catalog No.: HY-W179181
• CAS No.: 852702-51-3
• Molecular Formula: C14H12N2O6S
• Molecular Weight: 336.32
• Purity: 97.39%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Availability: In-stock

Source

Original product source